Compliance & Medical Disclaimer
This article is for informational and educational purposes only and does not constitute medical, legal, regulatory, or professional advice. The compounds discussed are research chemicals not approved for human consumption by the US FDA, European Medicines Agency (EMA), UK MHRA, Australian TGA, Health Canada, or any other major regulatory authority. They are sold strictly for laboratory research use. WolveStack does not employ medical staff, does not diagnose, treat, or prescribe, and makes no health claims under FTC, UK ASA, EU MDR/UCPD, or AU TGA standards. Always consult a licensed healthcare professional in your jurisdiction before considering any peptide protocol. This site contains affiliate links (FTC 2023 endorsement guidelines compliant); we may earn a commission on qualifying purchases at no additional cost to you. Some compounds discussed are on the WADA prohibited list — competitive athletes should verify current status with their governing body before any research use. Use of research chemicals may be illegal in your jurisdiction.
Editorial policy
Editorial review process: WolveStack Research Team — collective expertise in peptide pharmacology, regulatory science, and research literature analysis. We synthesize peer-reviewed studies, regulatory filings, and clinical trial data; we do not provide medical advice or treatment recommendations. Content is reviewed and updated as new evidence emerges.
Medical Disclaimer
For informational and educational purposes only. Not FDA-approved for human use. Consult a licensed healthcare professional. See full disclaimer.
Melanotan II is a synthetic melanocortin receptor agonist that stimulates melanin production for tanning, sexual arousal, and appetite suppression. It carries risks including nausea, blood pressure changes, melanoma concerns, and is illegal in many countries. No regulatory approval exists for human use; it remains a research chemical only.
What Exactly Is Melanotan II and How Was It Developed?
Melanotan II is a synthetic, non-selective melanocortin receptor agonist developed in the 1980s by researchers at the University of Arizona, led by Norman Levine. The original intent was photoprotection — activating melanin synthesis before UV exposure to reduce sunburn and skin cancer risk through a natural tanning mechanism.
The compound was never FDA-approved for human use. Clinical trials revealed potent sexual side effects (spontaneous erections, arousal enhancement), which led to a separate research program culminating in bremelanotide (PT-141), a more selective melanocortin agonist approved by the FDA for female sexual arousal disorder.
Melanotan II remains a research chemical without regulatory approval. It circulates in the research peptide market despite its unapproved status, making it one of the highest-selling compounds in this space.
Does Melanotan II Work Without Sun Exposure?
Yes, Melanotan II stimulates melanin production and skin darkening even without UV exposure through MC1R (melanocortin-1 receptor) activation in skin melanocytes. However, the tanning effect is substantially more pronounced when combined with UV light (sunlight or tanning beds).
Mechanism: MC1R activation drives melanin synthesis and increases antioxidant production in melanocytes. This intrinsic effect produces visible darkening (typically 1-2 shade increases) within 5-14 days of loading-phase dosing, even in the absence of sun exposure.
UV amplification: Combining MT-II with sunlight or tanning bed exposure produces dramatically more intense tanning (2-3+ shade increases) because UV radiation itself stimulates melanin synthesis in parallel. The two mechanisms synergize.
Is Melanotan II Legal to Possess and Use?
Regulatory status varies by jurisdiction. In the United States, Melanotan II is not FDA-approved for human use and is classified as a research chemical. Possession is technically legal for personal use in most states, though some states explicitly prohibit it.
United Kingdom and Australia: banned for human use by health regulators (MHRA and TGA respectively). Canada status is ambiguous — not explicitly approved but not explicitly banned. WADA (World Anti-Doping Agency) bans Melanotan II for athletic competition.
Always verify current legal status in your specific jurisdiction before obtaining or using Melanotan II.
What Are the Most Common Side Effects?
Nausea is the most frequently reported side effect, occurring in 40-60% of users during loading phase. Severity ranges from mild queasiness to severe vomiting requiring treatment cessation. Nausea typically peaks 30-60 minutes post-injection and resolves within 2-4 hours. Many users develop tolerance within 1-2 weeks despite unchanged dosing.
Facial flushing (redness and warmth) occurs in 20-40% of users, typically lasting 30 minutes to 2 hours post-injection. Involuntary erections in men are reported by 30-50% of users — a direct result of MC3R/MC4R activation.
Yawning and stretching at onset of action, appetite suppression from MC3R/MC4R activation, and other transient effects are commonly reported. Most resolve within hours to days.
Can Melanotan II Cause Melanoma or Skin Cancer?
This is the most serious safety concern. Melanotan II activates MC1R on all melanocytes, not just background skin cells. This means existing moles, freckles, and nevi also darken. The theoretical concern: could MC1R activation inadvertently stimulate growth or malignant transformation of atypical/dysplastic melanocytes?
Clinical evidence: No published controlled human studies have directly examined melanoma risk from MT-II. A single case report exists of a MT-II user developing melanoma, but causation was never established. Animal studies in melanoma-prone mouse models have not shown increased tumor formation.
Risk stratification: Individuals with family history of melanoma, personal history of skin cancer, atypical mole syndrome, or dysplastic nevi should avoid MT-II or use only under dermatological supervision. Baseline dermatology exam and photography is recommended before use.
What Are Melanotan II's Effects on Sexual Function?
Melanotan II produces potent sexual effects through non-selective melanocortin receptor activation in the hypothalamus and limbic system. MC3R and MC4R activation directly enhance sexual motivation, arousal, and erectile function in both men and women.
In men: spontaneous erections and enhanced erectile quality are commonly reported. Doses as low as 0.5-0.75 mg produce effects within 1-3 hours and last 4-12 hours.
In women: reports describe enhanced arousal, increased genital sensation, and improved sexual satisfaction. Effects are less visually obvious than in men but neurologically comparable. MT-II produces these effects systemically through melanocortin pathway activation — neurological rather than purely physiological.
How Does Melanotan II Compare to PT-141 (Bremelanotide)?
PT-141 is an FDA-approved melanocortin agonist marketed as VYLEESI for female sexual arousal disorder. It differs from MT-II in selectivity and safety profile. PT-141 is selective for MC3R and MC4R with minimal MC1R activity (no tanning effect). MT-II is non-selective across all melanocortin subtypes.
Result: PT-141 produces strong sexual effects with minimal tanning or nausea (5-10% vs 40-60% for MT-II). Cost: PT-141 costs $40-100 per dose; MT-II costs $8-15 per dose on the research market. The price difference reflects regulatory approval status and manufacturing standards.
What Is Melanotan II's Half-Life and Duration of Effects?
Melanotan II's pharmacokinetic half-life has not been precisely established in controlled human studies. However, behavioral effects (sexual arousal, appetite suppression) typically last 4-12 hours post-injection, suggesting a half-life in the 2-6 hour range.
Tanning effects persist much longer than acute behavioral effects. Melanin produced through MT-II stimulation persists in skin for weeks to months, gradually fading as melanocytes turn over and melanin is shed with skin cells.
For dosing implications: compounds accumulate when injected every other day, producing steady-state concentrations after 3-5 days. This explains why tanning effects intensify and behavioral side effects (nausea tolerance) develop over the first 1-2 weeks.
Can Melanotan II Be Used for Medical Purposes?
Research continues into potential therapeutic applications, but no approved medical uses exist currently. Theoretical applications under investigation include photoprotection (melanin production before solar exposure), sexual dysfunction treatment, and appetite regulation for obesity treatment.
None of these applications have progressed to clinical approval. PT-141 is FDA-approved, but MT-II's broader effects have not translated to medical advancement. Melanotan II remains a research chemical without approved medical indications, though research interest persists in academic and pharmaceutical contexts.
Trusted Research-Grade Sources
Below are the two vendors we recommend for research peptides — both publish independent third-party Certificates of Analysis (COAs) and ship internationally. Affiliate links: we earn a small commission at no extra cost to you (see Affiliate Disclosure).
Particle Peptides
Independently HPLC-tested, transparent COAs, comprehensive product range.
Browse Particle Peptides →Limitless Life Nootropics
Premium research peptides with strong customer support and verified purity.
Browse Limitless Life →FAQ: Melanotan II Frequently Asked Questions
Is Melanotan II effective for sensitive or dark skin types?
Melanotan II effectiveness varies by skin type. Fair-skinned individuals report more noticeable tan development (pale to medium brown). Individuals with medium to dark skin tones report less visible change in absolute terms but can still achieve measurable darkening. However, effectiveness is lower in dark skin types because they already have high baseline melanin levels. MT-II works best for fair-to-medium skin.
Can Melanotan II cause permanent skin darkening?
No. Melanotan II stimulates melanin production that eventually degrades and is shed with normal skin cell turnover (approximately every 28 days). Without continued maintenance injections, the tan fades completely within 4-8 weeks. The tan is biochemically similar to UV-induced tanning — temporary but renewably maintainable.
Does Melanotan II cause hair or nail darkening?
Yes, anecdotal reports describe darkening of body hair, eyebrows, and eyelashes. Nail darkening (melanonychia) has been reported but is less common. These effects occur because hair follicles and nail beds contain melanocytes and respond to MC1R activation like skin. Darkening is typically reversible.
What is the cost of Melanotan II?
Research market prices typically range from $8-20 per milligram of reconstituted peptide. A 10 mg vial (typical supply unit) costs $80-200 depending on vendor and purity certification. This provides 20-40 doses (250-500 mcg per dose), translating to $4-10 per injection — substantially cheaper than PT-141.
How should Melanotan II be stored?
Lyophilized powder: stable indefinitely at room temperature away from light and moisture. Reconstituted solution: stable for 30 days at room temperature (20-25°C) with bacteriostatic water. Refrigerated solutions (2-8°C) remain stable for 60+ days. Always use sterile technique to prevent bacterial contamination.
Is Melanotan II tested by third parties for purity?
Quality varies dramatically by vendor. Reputable research peptide suppliers (Ascension, Particle, Limitless) provide third-party HPLC purity testing and certificates of analysis. Many underground labs or low-cost suppliers provide no testing. Always demand to see HPLC purity data before purchase. Expect >95% purity from legitimate vendors.